These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1434216

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline.
    Lin CC, Liu CC, Lin CY.
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1503-6. PubMed ID: 8503562
    [Abstract] [Full Text] [Related]

  • 47. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
    Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, Benedict W, Zhang XQ, Lord EM, Litzky LA, Heitjan DF, June CH, Kaiser LR, Vonderheide RH, Albelda SM, Kanther M.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4456-66. PubMed ID: 17671130
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.
    Lissoni P, Barni S, Tancini G, Ardizzoia A, Tisi E, Angeli M, Rizzi A.
    Support Care Cancer; 1995 Jan 01; 3(1):78-80. PubMed ID: 7697307
    [Abstract] [Full Text] [Related]

  • 50. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
    Goey SH, Eggermont AM, Punt CJ, Slingerland R, Gratama JW, Oosterom R, Oskam R, Bolhuis RL, Stoter G.
    Br J Cancer; 1995 Nov 01; 72(5):1283-8. PubMed ID: 7577483
    [Abstract] [Full Text] [Related]

  • 51. Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease.
    Yanagawa H, Yano S, Haku T, Ohmoto Y, Sone S.
    Eur Respir J; 1996 Jun 01; 9(6):1211-6. PubMed ID: 8804940
    [Abstract] [Full Text] [Related]

  • 52. Elevation of interleukin-10 levels in malignant pleural effusion.
    Chen YM, Yang WK, Whang-Peng J, Kuo BI, Perng RP.
    Chest; 1996 Aug 01; 110(2):433-6. PubMed ID: 8697847
    [Abstract] [Full Text] [Related]

  • 53. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.
    Chung CL, Chen YC, Chang SC.
    Chest; 2003 Apr 01; 123(4):1188-95. PubMed ID: 12684310
    [Abstract] [Full Text] [Related]

  • 54. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study.
    Yasumoto K, Ogura T.
    Biotherapy; 1991 Apr 01; 3(4):345-9. PubMed ID: 1786198
    [Abstract] [Full Text] [Related]

  • 55. Induction of cytolytic activity of lymphocytes from carcinomatous pleural effusion by IL-2 and autologous tumor cells.
    Sairenji M, Yanoma S, Motohashi H, Kobayashi O, Okada K, Okamoto T, Tsukuda M, Umeda M.
    Biotherapy; 1993 Apr 01; 6(4):283-90. PubMed ID: 8018449
    [Abstract] [Full Text] [Related]

  • 56. Interleukin 22-producing CD4+ T cells in malignant pleural effusion.
    Ye ZJ, Zhou Q, Yin W, Yuan ML, Yang WB, Xiang F, Zhang JC, Xin JB, Xiong XZ, Shi HZ.
    Cancer Lett; 2012 Dec 29; 326(1):23-32. PubMed ID: 22809567
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.
    Astoul P, Viallat JR, Laurent JC, Brandely M, Boutin C.
    Chest; 1993 Jan 29; 103(1):209-13. PubMed ID: 8417880
    [Abstract] [Full Text] [Related]

  • 60. Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage.
    Bjermer L, Grönberg H, Roos G, Henriksson R.
    Biotherapy; 1993 Jan 29; 6(1):1-7. PubMed ID: 8507539
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.